05:58 PM EDT, 10/06/2025 (MT Newswires) -- ESSA Pharma ( EPIX ) won near-unanimous shareholder approval for its acquisition by XenoTherapeutics.

The transaction remains subject to the approval of the Supreme Court of British Columbia and other closing conditions, ESSA said Monday in a statement.

The court hearing for the final order is scheduled for Tuesday, and the buyout is expected to be completed around Thursday.